| |
|
|
|
Diamedica Therapeutics Inc  
|
|
4.31 0.1 (0.02%) |
10-23 16:00 |
|
Open: |
4.38 |
Pre close: |
4.21 |
Target:
|
5.30
|
|
High: |
4.46 |
Low: |
4.2 |
Resistance:
|
4.54
5.01
|
|
Volume: |
10,664 |
Market Cap: |
81M |
Support:
|
3.77
3.14
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.34
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
4.44  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
5.25 |
Stochastic Oscillator |
%K(14,3):
|
21.10 |
|
MA(250): |
4.41 |
%D(3): |
28.54 |
|
Average Volume(K) |
3-Month: |
6095
|
52-Week |
High:
|
8.80 |
|
10-Days: |
4385 |
Low: |
1.87 |
|
RSI |
RSI(14):
|
46.21 |
Change(%): |
40.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.767 |
Return on Equity (ttm) |
-85.6 |
Shares Out. (M) |
18.74 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-51.9 |
Shares Float (M) |
16.85 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.04 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.26 |
|
Forward EPS |
-0.740 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
21 |
|
Book Value (p.s.) |
0.800 |
EBITDA (p.s.) |
-0.561 |
P/E |
-5.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.39 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.92 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.91 |
P/CF |
-11.67 |
|
|
|
|
|
|
